SCHEMBL6199677

SCHEMBL6199677

CCOC(=O)N1c2cc3c(cc2C(N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OCCOC)CC1C)CCC3

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CETP P11597 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6199674 1.00 CETP (0.54) CETP
SCHEMBL6398393 0.92 CETP (0.64) CETP
SCHEMBL1242569 0.92 CETP (0.64) CETP
SCHEMBL992496 0.92 CETP (0.64) CETP
SCHEMBL6588165 0.89 CETP (0.63) CETP
SCHEMBL6588803 0.89 CETP (0.63) CETP
SCHEMBL6198972 0.88 CETP (0.53) CETP
SCHEMBL6198969 0.88 CETP (0.53) CETP
SCHEMBL6588964 0.88 CETP (0.53) CETP
SCHEMBL6588960 0.88 CETP (0.53) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0992496-B1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors PFIZER PROD INC (US) 2005-08-10 EP disclosed
US-6147089-A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS USED TO TREAT DISEASES WHICH ARE EXACERBATED BY LOW LEVELS OF HDL CHOLESTEROL AND/OR HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES, SUCH AS ATHEROSCLEROSIS AND CARDIOVASCULAR PFIZER INC. (US) 2000-11-14 US disclosed
EP-0992496-A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors Pfizer Products Inc. (US) 2000-04-12 EP disclosed